DealSling Therapeutics, Inc., an Ann Arbor, MI-based thyroid eye disease therapeutics company, raised $123 million in a Series C fundraising round led by Forbion with participation from TPG Life Sciences Innovations and Sectoral Asset Management.
More on VCNewsDaily →
SERIES C
09/29/2026
Allara, a New York-based virtual women’s health platform, raised $30...
MakeO, a Mumbai-based direct-to-consumer dental-care platform, raised...
Geneticure, a Rochester, MN-based precision medicine company, raised $1...
Emerald, a London-based preventive health platform, raised £1.4 million...
Vitonnix, a Birmingham-based healthcare technology startup, raised an...
The Stack, a Panaji, India-based sports nutrition supplements brand,...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
